Prevalence in the United States of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme
about
Plasmid-mediated quinolone resistance: a multifaceted threatAnalysis of drug resistance determinants in Klebsiella pneumoniae isolates from a tertiary-care hospital in Beijing, ChinaStructural diversity of class 1 integrons and their associated gene cassettes in Klebsiella pneumoniae isolates from a hospital in ChinaThe growing burden of antimicrobial resistance.Emergence of human pandemic O25:H4-ST131 CTX-M-15 extended-spectrum-beta-lactamase-producing Escherichia coli among companion animals.Limited transmission of bla(CTX-M-9)-type-positive Escherichia coli between humans and poultry in Vietnam.Fecal carriage of CTX-M β-lactamase-producing Enterobacteriaceae in nursing homes in the Kinki region of Japan.Prevalence and molecular characterization of extended-spectrum β-lactamase (ESBL) and plasmidic AmpC β-lactamase (pAmpC) producing Escherichia coli in dogs.Cholera outbreaks in Nigeria are associated with multidrug resistant atypical El Tor and non-O1/non-O139 Vibrio cholerae.Transformation of N-phenylpiperazine by mixed cultures from a municipal wastewater treatment plantPredictive analysis of transmissible quinolone resistance indicates Stenotrophomonas maltophilia as a potential source of a novel family of Qnr determinantsGenetic diversity of Salmonella enteric serovar typhi and paratyphi in Shenzhen, China from 2002 through 2007Molecular epidemiology of metallo-beta-lactamase-producing Pseudomonas aeruginosa isolates from Norway and Sweden shows import of international clones and local clonal expansionUnique Features of Aeromonas Plasmid pAC3 and Expression of the Plasmid-Mediated Quinolone Resistance GenesCharacteristics of Escherichia coli sequence type 131 isolates that produce extended-spectrum β-lactamases: global distribution of the H30-Rx sublineage.Carbapenem-resistant Klebsiella pneumoniae strains exhibit diversity in aminoglycoside-modifying enzymes, which exert differing effects on plazomicin and other agents.Isolation of Escherichia coli strains with AcrAB-TolC efflux pump-associated intermediate interpretation or resistance to fluoroquinolone, chloramphenicol and aminopenicillin from dogs admitted to a university veterinary hospitalAntibiotics and bacterial resistance in the 21st century.The characterization and antibiotic resistance profiles of clinical Escherichia coli O25b-B2-ST131 isolates in KuwaitPrevalence of plasmid-mediated quinolone resistance genes among ciprofloxacin-nonsusceptible Escherichia coli and Klebsiella pneumoniae isolated from blood cultures in KoreaAntibiotic-resistant Escherichia coli bacteria, including strains with genes encoding the extended-spectrum beta-lactamase and QnrS, in waterbirds on the Baltic Sea Coast of PolandEpidemiology of plasmid-mediated quinolone resistance in salmonella enterica serovar typhimurium isolates from food-producing animals in Japan.Antibiotic resistance in uropathogenic e. Coli strains isolated from non-hospitalized patients in pakistan.Type II and type IV topoisomerase mutations in clinical isolates of Morganella morganii harbouring the qnrD gene.Characterization of fluoroquinolone-resistant Shigella flexneri in Hangzhou area of China.A high throughput multiplex PCR assay for simultaneous detection of seven aminoglycoside-resistance genes in Enterobacteriaceae.Molecular characterization of multidrug-resistant extended-spectrum β-lactamase-producing Enterobacteriaceae isolated in Antananarivo, Madagascar.Analysis for prevalence and physical linkages amongst integrons, ISEcp1, ISCR1, Tn21 and Tn7 encountered in Escherichia coli strains from hospitalized and non-hospitalized patients in Kenya during a 19-year period (1992-2011).Cross-sectional study on prevalence and molecular characteristics of plasmid mediated ESBL/AmpC-producing Escherichia coli isolated from veal calves at slaughter.Plasmid-mediated quinolone resistance.Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms.First characterization of CTX-M-15-producing Escherichia coli ST131 and ST405 clones causing community-onset infections in South America.Comparison of ESBL--and AmpC producing Enterobacteriaceae and methicillin-resistant Staphylococcus aureus (MRSA) isolated from migratory and resident population of rooks (Corvus frugilegus) in AustriaA degenerate PCR-based strategy as a means of identifying homologues of aminoglycoside and β-lactam resistance genes in the gut microbiota.Extended-spectrum-beta-lactamases, AmpC beta-lactamases and plasmid mediated quinolone resistance in klebsiella spp. from companion animals in Italy.Emergence of extended-spectrum beta-lactamase (CTX-M-15 and CTX-M-14)-producing nontyphoid Salmonella with reduced susceptibility to ciprofloxacin among food animals and humans in Korea.Quinolone resistance mechanisms among extended-spectrum beta-lactamase (ESBL) producing Escherichia coli isolated from rivers and lakes in Switzerland.Multiresistant extended-spectrum β-lactamase-producing Enterobacteriaceae from humans, companion animals and horses in central Hesse, GermanyNon-phenotypic tests to detect and characterize antibiotic resistance mechanisms in Enterobacteriaceae.Molecular epidemiology and genetic diversity of fluoroquinolone-resistant Escherichia coli isolates from patients with community-onset infections in 30 Chinese county hospitals
P2860
Q24645356-64EF30F4-84AB-4B96-9396-055EA60B8D91Q28481714-F3EBD246-E902-4D89-9382-9B203DB0C977Q28533900-CDF550FE-F910-4ED3-A7EA-CE4A33DDE904Q30371239-1342A1C5-C3FE-400D-BD05-198171BCFB9FQ30385107-EEA5B7CD-E2ED-4D58-8225-611C50674B45Q30386767-C41A61E9-EAA8-4287-A21D-2CCB0B29E41FQ30393407-868F6909-885A-40AC-803E-A871D21DA9E6Q30401450-FCB810E0-2817-4611-BBD9-1A41B4787415Q30427821-76F795F0-A59D-4CCB-8139-E9171569673BQ31168336-1C20281C-9516-4B92-AB4B-0BC8A1939970Q33369591-702AD255-F3A7-46EF-9F65-B48DF9AC646CQ33527574-CC0AA9DB-C1B7-4AFF-9F45-9CBB36939E83Q33559180-58D497EA-BA1C-40E8-B421-5DD7B5C8A7A7Q33726354-3273D357-13D3-4962-A44B-B87E70AE625CQ33798233-4E150108-6FBA-4FCE-8837-CE1D8C3F2DD1Q34058006-CC09064B-4DD1-4D9C-84F4-915C278D5D9EQ34085440-B2377087-56A7-43D5-9024-6D4C09876208Q34156349-DE9472DA-23AC-4E18-96AB-D32450DDAECEQ34157129-772CAC71-C064-4913-B3A9-EF25E3AC5DF7Q34238560-DBEC26AA-AFFA-4B30-9390-6B2FEF24E298Q34432199-AE98BD12-454E-4278-A0C6-17C55DED5FB3Q34477960-9DE13492-D747-4663-8FE9-3CF8F57952C0Q34479623-EF1317AD-AADE-451C-901D-37536E947692Q34538010-61267ECC-6547-44CE-9F4C-39F11BBBBACEQ34605549-CA31C91D-02B4-4C7E-9EE6-F4CA861E5FBBQ34622837-F26782DB-3405-4F31-AE09-1AA03580369CQ34675362-ADF32A23-225F-4AFE-A7B9-CC59FD11CE4BQ34727309-7AD769AE-5C88-46CB-AD8E-DAD6DB36B965Q34750125-6E033C21-3A02-4DCC-B338-74C23277A889Q34888920-08D3CA8E-AE30-4ADC-B54A-43C0654D268AQ35007624-73EA0416-1FEF-4936-88E5-D7DF48D34B41Q35066516-29EDFE24-11C9-45FF-BE5C-19FBD42963B3Q35082753-CC34EA5C-DEF8-4236-A3CA-02E9D9F3916EQ35086954-E0ACF6C7-658A-4FCE-A3E1-0000294EBE5BQ35111248-7976C265-6853-413E-AF6E-66953426D5A9Q35140199-E7B6E838-9BF4-40A3-ADD5-277F86BF410BQ35155107-99294873-E387-44B7-B507-70A036AB7C6AQ35205641-6053450D-1406-4568-84E2-3207F614E28DQ35297743-7DE980CE-1784-40EA-8C70-DF59D8AA6162Q35331113-D1AACFE4-2D11-48CD-A568-1C5CFBA0501C
P2860
Prevalence in the United States of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Prevalence in the United State ...... ciprofloxacin-modifying enzyme
@ast
Prevalence in the United State ...... ciprofloxacin-modifying enzyme
@en
type
label
Prevalence in the United State ...... ciprofloxacin-modifying enzyme
@ast
Prevalence in the United State ...... ciprofloxacin-modifying enzyme
@en
prefLabel
Prevalence in the United State ...... ciprofloxacin-modifying enzyme
@ast
Prevalence in the United State ...... ciprofloxacin-modifying enzyme
@en
P2093
P2860
P356
P1476
Prevalence in the United State ...... ciprofloxacin-modifying enzyme
@en
P2093
Ari Robicsek
Chi Hye Park
Daniel Sahm
David C Hooper
George A Jacoby
P2860
P304
P356
10.1128/AAC.00915-06
P407
P577
2006-09-05T00:00:00Z